Literature DB >> 27552366

Use of Antipsychotics During Pregnancy: Pregnant Women Get Sick-Sick Women Get Pregnant.

Katherine L Wisner1, Hyunyoung Jeong2, Christina Chambers3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27552366      PMCID： PMC5933928          DOI： 10.1001/jamapsychiatry.2016.1538

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  11 in total

1.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

Authors:  Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2011-04-22       Impact factor: 8.661

2.  Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.

Authors:  Rikus Knegtering; Pepijn Baselmans; Stynke Castelein; Fokko Bosker; Richard Bruggeman; Robert J van den Bosch
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

3.  Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.

Authors:  Claudia M Klier; Nilufar Mossaheb; Alois Saria; Monika Schloegelhofer; Gerald Zernig
Journal:  J Clin Psychopharmacol       Date:  2007-12       Impact factor: 3.153

Review 4.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

Authors:  Shlomo Melmed; Felipe F Casanueva; Andrew R Hoffman; David L Kleinberg; Victor M Montori; Janet A Schlechte; John A H Wass
Journal:  J Clin Endocrinol Metab       Date:  2011-02       Impact factor: 5.958

5.  Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.

Authors:  Kristina I Melkersson
Journal:  Hum Psychopharmacol       Date:  2006-12       Impact factor: 1.672

6.  Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?

Authors:  David M Haas; Mary DʼAlton
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

Review 7.  Management of bipolar disorder during pregnancy and the postpartum period.

Authors:  Kimberly A Yonkers; Katherine L Wisner; Zachary Stowe; Ellen Leibenluft; Lee Cohen; Laura Miller; Rachel Manber; Adele Viguera; Trisha Suppes; Lori Altshuler
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

Review 8.  Alterations in drug disposition during pregnancy: implications for drug therapy.

Authors:  Lucy S Hodge; Timothy S Tracy
Journal:  Expert Opin Drug Metab Toxicol       Date:  2007-08       Impact factor: 4.481

9.  Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting.

Authors:  Cheryl S Broussard; Meghan T Frey; Sonia Hernandez-Diaz; Michael F Greene; Christina D Chambers; Leyla Sahin; Beth A Collins Sharp; Margaret A Honein
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

10.  Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.

Authors:  Bruce J Kinon; Julie A Gilmore; Hong Liu; Uriel M Halbreich
Journal:  Psychoneuroendocrinology       Date:  2003-04       Impact factor: 4.905
View more
  2 in total

1.  Clinical trials in pregnancy and the "shadows of thalidomide": Revisiting the legacy of Frances Kelsey.

Authors:  Miranda R Waggoner; Anne Drapkin Lyerly
Journal:  Contemp Clin Trials       Date:  2022-05-30       Impact factor: 2.261

Review 2.  Precision medicine in perinatal depression in light of the human microbiome.

Authors:  Beatriz Peñalver Bernabé; Pauline M Maki; Shannon M Dowty; Mariana Salas; Lauren Cralle; Zainab Shah; Jack A Gilbert
Journal:  Psychopharmacology (Berl)       Date:  2020-02-17       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.